Impact of the spread of COVID-19 on business performance
First written in FY2021-Q1. 6 of 7 entries say "Restated". Latest entry: FY2023-Q3.
The whole theme swung hardest in 2023: 3 of 36 companies on the "Worse" side.
39 other companies' latest entry also says "Restated".
- FY2023-Q3RestatedAnnual report
「There have been no material changes to the assumptions concerning the impact of the spread of COVID-19 described in the additional information section of the securities report for the previous consolidated fiscal year, under "Accounting Estimates Related to the Spread of COVID-19."」
The company reconfirmed that there were no material changes to the assumptions underlying its accounting estimates concerning the impact of COVID-19. - FY2023-Q2RestatedAnnual report
「There have been no material changes to the assumptions concerning the impact of the spread of COVID-19 described in the additional information section of the securities report for the previous consolidated fiscal year, under "Accounting Estimates Related to the Spread of COVID-19."」
The company reconfirmed that there were no material changes to the assumptions underlying its accounting estimates concerning the impact of COVID-19. - FY2022-Q3RestatedAnnual report
「There have been no material changes to the assumptions concerning the impact of the spread of COVID-19 described in the additional information section of the securities report for the previous consolidated fiscal year, under "Accounting Estimates Related to the Spread of COVID-19."」
The company reconfirmed that there were no material changes to the assumptions underlying its accounting estimates concerning the impact of COVID-19. - FY2022-Q1RestatedAnnual report
「There have been no material changes to the assumptions concerning the impact of the spread of COVID-19 described in the additional information section of the securities report for the previous consolidated fiscal year, under "Accounting Estimates Related to the Spread of COVID-19."」
The company reconfirmed that there were no material changes to the assumptions underlying its accounting estimates concerning the impact of COVID-19. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter, the Group experienced no adverse effects from COVID-19, such as lower revenue or higher costs. However, if a significant impact on the Group's management is identified in the future, we will disclose it promptly.」
The company reported no adverse effects from COVID-19, such as lower revenue or higher costs, during the cumulative third quarter, and reaffirmed its policy of making a public disclosure if a significant future impact is identified. - FY2021-Q2RestatedAnnual report
「During the six-month period ended 30 September, there was no adverse impact from COVID-19, such as a decrease in our group's sales or an increase in expenses. However, if a material impact on our group's management is identified in the future, we will promptly disclose it.」
Although there were no adverse effects from COVID-19, such as lower revenue or higher costs, during the quarter, the company has reaffirmed its policy of publicly disclosing any significant future effects. - FY2021-Q1First statedAnnual report
「During the first quarter of the consolidated fiscal period, there was no adverse impact from COVID-19, such as a decrease in our group's sales or an increase in expenses. However, if a material impact on our group's management is identified in the future, we will promptly disclose it.」
States that the spread of COVID-19 had no adverse impact, such as lower sales or higher expenses, during the quarter, while indicating a policy of disclosure if a material impact is identified in the future.